The main focus of my research program is the quality of care received by patients with cancer especially in regards to delivery of systemic therapy. I am also interested in understanding the evolution and dissemination of findings from randomized controlled trials in cancer.
Cancer Med. 2019 Aug 31;:
Karim S, Mackillop WJ, Brennan K, Peng Y, Siemens DR, Krzyzanowska MK, Booth CM
Cancer Med. 2019 Aug 12;:
Karim S, Booth CM, Brennan K, Peng Y, Siemens DR, Krzyzanowska MK, Mackillop WJ
Support Care Cancer. 2019 Jun 04;:
Sorensen A, Wentlandt K, Le LW, Swami N, Hannon B, Rodin G, Krzyzanowska MK, Zimmermann C
Ecancermedicalscience. 2019;13:ed88
Riechelmann RP, Krzyzanowska MK
CMAJ. 2019 Apr 23;191(16):E436-E445
Grewal K, Sutradhar R, Krzyzanowska MK, Redelmeier DA, Atzema CL
J Med Internet Res. 2019 Mar 28;21(3):e9958
Prince RM, Soung Yee A, Parente L, Enright KA, Grunfeld E, Powis M, Husain A, Gandhi S, Krzyzanowska MK
Pilot Feasibility Stud. 2019;5:39
Krzyzanowska MK, MacKay C, Han H, Eberg M, Gandhi S, Laferriere NB, Powis M, Howell D, Atzema CL, Chan KKW, Kukreti V, Mitchell S, Nayer M, Pasetka M, Knittel-Keren D, Redwood E
JMIR Cancer. 2018 Dec 21;4(2):e10932
Moradian S, Krzyzanowska MK, Maguire R, Morita PP, Kukreti V, Avery J, Liu G, Cafazzo J, Howell D
J Oncol Pract. 2018 Dec;14(12):757-759
Kamal AH, Krzyzanowska MK
Eur J Cancer Care (Engl). 2018 Sep 20;:e12909
Prince RM, Powis M, Zer A, Atenafu EG, Krzyzanowska MK



Medical Oncologist, Princess Margaret Cancer Centre
Associate Professor of Medicine, University of Toronto
Clinical Lead, Quality Care and Access, Systemic Treatment Program, Cancer Care Ontario
Adjuct Scientist, Institute for Clinical Evaluative Sciences